Jeremy Koppel

Summary

Affiliation: Long Island Jewish Medical Center
Country: USA

Publications

  1. doi request reprint Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, The North Shore Long Island Jewish Health System, Manhasset, NY, USA
    Am J Geriatr Psychiatry 20:994-1000. 2012
  2. pmc Targeting the endocannabinoid system in Alzheimer's disease
    Jeremy Koppel
    The Albert Einstein College of Medicine and The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    J Alzheimers Dis 15:495-504. 2008
  3. pmc Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    Lipids Health Dis 8:2. 2009
  4. ncbi request reprint The genetics of episodic memory
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    Cogn Neuropsychiatry 14:356-76. 2009
  5. pmc Performance-based measures of everyday function in mild cognitive impairment
    Terry E Goldberg
    Litwin Zucker Center for Research in Alzheimer s Disease and Memory Disorders, Feinstein Institute for Medical Research, 350 Community Dr, Manhassett, NY 11030, USA
    Am J Psychiatry 167:845-53. 2010
  6. pmc CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease
    Jeremy Koppel
    Litwin Zucker Research Center for the Study of Alzheimer s Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA
    Mol Med 17:974-9. 2011
  7. ncbi request reprint APOE Genotype Modulates Proton Magnetic Resonance Spectroscopy Metabolites in the Aging Brain
    Jesús J Gomar
    Litwin Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, New York FIDMAG Hermanas Hospitalarias, Sant Boi de Llobregat, Spain
    Biol Psychiatry 75:686-92. 2014
  8. ncbi request reprint Semantic distance abnormalities in mild cognitive impairment: their nature and relationship to function
    Brady C Kirchberg
    Litwin Zucker Center for Research in Alzheimer s Disease and Memory Disorders, Feinstein Institute for Medical Research, Manhasset, NY, USA
    Am J Psychiatry 169:1275-83. 2012
  9. pmc An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease
    Marc L Gordon
    The Litwin Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, N Y, USA
    Dement Geriatr Cogn Dis Extra 2:312-20. 2012
  10. ncbi request reprint Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease, The Feinstein Institute for Medical Research, Manhasset, NY, USA The Zucker Hillside Hospital, The North Shore LIJ Health System, Glen Oaks, NY, USA Electronic address
    Neurobiol Aging 35:2021-8. 2014

Collaborators

Detail Information

Publications11

  1. doi request reprint Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, The North Shore Long Island Jewish Health System, Manhasset, NY, USA
    Am J Geriatr Psychiatry 20:994-1000. 2012
    ....
  2. pmc Targeting the endocannabinoid system in Alzheimer's disease
    Jeremy Koppel
    The Albert Einstein College of Medicine and The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    J Alzheimers Dis 15:495-504. 2008
    ..Here we present a review of endocannabinoid physiology, the evidence that underscores its utility as a potential target for intervention in Alzheimer's disease, and suggest future pathways of research...
  3. pmc Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    Lipids Health Dis 8:2. 2009
    ..To date, no published studies have investigated the potential utility of circulating eCBs as diagnostic biomarkers for AD or the impact of central eCBs on cognition...
  4. ncbi request reprint The genetics of episodic memory
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease and Memory Disorders, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    Cogn Neuropsychiatry 14:356-76. 2009
    ..To date, several candidate genes have been explored and a few seem to have modest but measurable effects...
  5. pmc Performance-based measures of everyday function in mild cognitive impairment
    Terry E Goldberg
    Litwin Zucker Center for Research in Alzheimer s Disease and Memory Disorders, Feinstein Institute for Medical Research, 350 Community Dr, Manhassett, NY 11030, USA
    Am J Psychiatry 167:845-53. 2010
    ....
  6. pmc CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease
    Jeremy Koppel
    Litwin Zucker Research Center for the Study of Alzheimer s Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA
    Mol Med 17:974-9. 2011
    ..These data further demonstrate the utility of endophenotype-based approaches focusing on CSF biomarkers for the identification or validation of risk factors for AD...
  7. ncbi request reprint APOE Genotype Modulates Proton Magnetic Resonance Spectroscopy Metabolites in the Aging Brain
    Jesús J Gomar
    Litwin Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, New York FIDMAG Hermanas Hospitalarias, Sant Boi de Llobregat, Spain
    Biol Psychiatry 75:686-92. 2014
    ..We aimed to quantify brain metabolite changes in healthy subjects in relation to age and the presence of the APOE E4 genetic risk factor for Alzheimer's disease. Additionally, we examined these measures in relation to cognition...
  8. ncbi request reprint Semantic distance abnormalities in mild cognitive impairment: their nature and relationship to function
    Brady C Kirchberg
    Litwin Zucker Center for Research in Alzheimer s Disease and Memory Disorders, Feinstein Institute for Medical Research, Manhasset, NY, USA
    Am J Psychiatry 169:1275-83. 2012
    ..The authors sought to directly examine compromises in the semantic system in mild cognitive impairment and their possible relationship to everyday functional competencies...
  9. pmc An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease
    Marc L Gordon
    The Litwin Zucker Research Center, The Feinstein Institute for Medical Research, Manhasset, N Y, USA
    Dement Geriatr Cogn Dis Extra 2:312-20. 2012
    ..To characterize progression of Alzheimer's disease (AD) using proton magnetic resonance spectroscopy ((1)H MRS)...
  10. ncbi request reprint Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities
    Jeremy Koppel
    The Litwin Zucker Research Center for the Study of Alzheimer s Disease, The Feinstein Institute for Medical Research, Manhasset, NY, USA The Zucker Hillside Hospital, The North Shore LIJ Health System, Glen Oaks, NY, USA Electronic address
    Neurobiol Aging 35:2021-8. 2014
    ..The design of future studies aimed at the elucidation of cognitive and/or functional outcomes; regional brain metabolic deficits; or genetic correlates of AD + P should take gender into consideration. ..
  11. pmc Mechanism-based treatments for Alzheimer's disease
    Peter Davies
    Litwin Zucker Center for Research on Alzheimer s Disease, Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
    Dialogues Clin Neurosci 11:159-69. 2009
    ..It is as yet unclear which, if any, of these approaches will be successful, but the high level of activity in each of these three fields provides some hope that an effective treatment for Alzheimer's disease is on the horizon...